"Some members have gone so far as writing us personal notes to say that No Pay Copay helped their families afford needed medications in 2007 and that they will continue to save money by asking for generics," said Frick, adding that IBC offers a wide array of drug plans that make access to generics easy for members.
Generics typically cost up to 70 percent less than the comparable brand name drugs. The lower costs for generic drugs are generally associated with the lower marketing and development costs for those drugs.
The IBC survey was conducted by DSS Research, a leading national health
care research and consulting firm headquartered in Fort Worth, Texas. In
September, DSS interviewed 805 adult IBC members in the five-county
southeastern Pennsylvania area and the surrounding region who were eligible
for IBC's No Pay Copay during 2007. The margin of error on the overall
sample was +/- 3.5 percent.
Additional Survey Findings
Perception of Generics
No Pay Copay clearly improved members' understanding of and confidence in
- An encouraging 87 percent of surveyed members said they are likely to
ask for generics after No Pay Copay ends, demonstrating their confidence
in the safety and effectiveness of generics over brand name drugs.
- Forty-four percent of surveyed members said they would not have asked
for generics in the past but have begun to or will ask for generics
after learning more about them through No Pay Copay in 2007.
- More than 70 percent of those surveyed already had a favorable
impression of generics before No Pay Copay. Now, 45 percent claim they
have an even better impression of generics.
Generic Use in Members with Chronic Conditions
Those members who are t
|SOURCE Independence Blue Cross|
Copyright©2007 PR Newswire.
All rights reserved